The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Managing Mounjaro Nausea: How It Compares to Wegovy
Nausea is one of the most common side effects when starting Mounjaro or Wegovy, though it typically improves over time as your body adjusts. Both medications can cause nausea, but understanding the differences between them — including how their mechanisms work and what clinical trial data shows — can help you and your prescriber decide which might suit you better. This guide compares nausea relief approaches and side effect profiles for both GLP-1 and dual GIP/GLP-1 medications available in the UK.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Mounjaro and Wegovy Cause Nausea: Mechanism Differences
Nausea occurs because both Mounjaro (tirzepatide) and Wegovy (semaglutide) affect how quickly food moves through your stomach and how your brain perceives appetite. Mounjaro is a dual GIP and GLP-1 receptor agonist, meaning it activates two separate hormone pathways, which may contribute to a stronger appetite-suppressing effect. Wegovy is a GLP-1 agonist only, activating a single pathway. In the SURMOUNT clinical trial, nausea was reported by approximately 25% of participants on the highest dose of Mounjaro, while in the STEP trials for Wegovy, nausea affected approximately 25–30% of participants at maximum dose.
- Nausea typically emerges during the dose escalation phase (weeks 1–4 on each new dose)
- Most participants report that nausea improves after 4–8 weeks on a stable dose
- Mechanisms differ: Mounjaro's dual action may cause different nausea patterns than Wegovy's single pathway
- Individual tolerance varies — some people experience minimal nausea, others more significant symptoms
Neither medication assures less nausea than the other; it depends on your individual physiology and how your body responds to hormone pathway activation.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Which Medication Might Be Right for You: A Prescriber's Perspective
Your prescriber will consider nausea tolerance alongside other factors when deciding between Mounjaro and Wegovy. Neither is universally "better" for nausea relief — the choice depends on your medical history, other medications, and individual response patterns. Both require a clinical assessment before prescription in the UK, and your prescriber will assess your personal eligibility and suitability.
- If you have a history of severe nausea or gastric sensitivity, discuss this with your prescriber before starting either medication
- Dose titration (slow increases) helps minimise nausea — both medications use gradual escalation schedules
- Practical nausea management applies to both: eating smaller meals, staying hydrated, and taking medication at consistent times can help
- Your prescriber may recommend starting at the lowest dose and escalating very slowly if nausea is a concern
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro cause more nausea than Wegovy?
Clinical trials show similar nausea rates (~25–30%) for both at maximum doses. Individual experience varies significantly. Some people tolerate Mounjaro better, others prefer Wegovy. Your prescriber will assess which suits your individual health profile.
What's the difference between Mounjaro and Wegovy mechanisms?
Mounjaro is a dual GIP and GLP-1 agonist (two pathways), while Wegovy is a GLP-1 agonist only (one pathway). This may create different side effect profiles, but both cause nausea in roughly similar proportions during clinical trials.
How long does nausea last when taking Mounjaro?
Nausea typically peaks during dose escalation (weeks 1–4 on each new dose) and improves within 4–8 weeks on a stable dose. Most people find it manageable after the first month. If severe nausea persists, contact your prescriber.
Can I reduce nausea by eating smaller meals?
Yes. Both Mounjaro and Wegovy slow stomach emptying, so smaller, more frequent meals help. Stay hydrated, avoid greasy foods, and eat slowly. These practical strategies work for both medications and can significantly ease nausea.
Will my GP prescribe Mounjaro or Wegovy based on nausea risk?
Your prescriber will consider nausea tolerance alongside your BMI, health conditions, and medication history. Both are prescription-only and available through NHS specialist services or private online prescribing in the UK following clinical assessment.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.